2024-515250-25-00Not yet recruitingPhase 1
K-SAB trial
Source: EU CTIS (euclinicaltrials.eu) · Last updated 25 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 14 Oct 2024
- Start date
- 1 Apr 2023
- Lead sponsor
- Karolinska University Hospital
- Diseases
- Lung cancer
- EU CT number
- 2024-515250-25-00
- EudraCT number
- 2022-002322-27
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 20
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with advanced non-small cell lung cancer that carries a KRAS G12C change. They either got worse after at least one earlier treatment, or cannot have immunotherapy or chemotherapy.
- Age
- 18 years or older
- Sex
- Men and women can join
- Disease stage
- Advanced non-small cell lung cancer
- Earlier treatment
- The cancer got worse after at least one earlier line of treatment, or immunotherapy or chemotherapy is not possible for the person
- Biomarker or test result
- KRAS G12C mutation
Read by machine on 9 Nov 2026.
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sahlgrenska University Hospital-Vaestra Goetalandsregionen | Goteborg | Sweden | Not yet recruiting |
| Karolinska University Hospital | Solna | Sweden | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.